Obesity and Hypertension in Primary Health Care Units: Profile and Association in a Municipality in Southern Brazil
DOI:
https://doi.org/10.36557/2674-9432.2026v5n3p243-255Keywords:
Obesity, Hypertension, Primary Health Care, Health Units, Chronic DiseasesAbstract
Objective: To analyze the distribution of obesity and arterial hypertension among users of different Primary Health Care Units (UBS) in a municipality in Paraná, examining the association of sex and health unit with these conditions. Methods: Cross-sectional retrospective study using data from 3,434 medical records of adults treated at three Primary Health Care Units in Ponta Grossa, Paraná, between 2015 and 2021. Information on weight, height, blood pressure, and sex were collected. Obesity was defined as BMI ≥ 30, and hypertension as blood pressure ≥ 140/90 mmHg. Descriptive analysis and chi-square tests were performed (p ≤ 0.05). Results: The prevalence of obesity was 33.5%, and that of hypertension was 30.8%. Obese individuals showed a significantly higher prevalence of hypertension (47.2%) compared to non-obese individuals (23.3%) (p < 0.001). Obesity was more frequent in women (35.3%), whereas hypertension was more prevalent in men (39.9%) (p < 0.001). The highest prevalence of hypertension was observed in the Silas Sallen Health Unit (38.2%), and the lowest in the Jamil Mussi Health Unit (23.7%). Conclusions: A significant association between obesity and arterial hypertension was observed, with important variations according to sex and health unit. The findings reinforce the importance of targeted prevention and management strategies in Primary Health Care, especially for the most vulnerable groups.
Downloads
References
1.Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.
2.Bahia L, Coutinho ESF, Barufaldi LA, et al. The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study. BMC Public Health. 2012;12:440.
3.BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise em Saúde e Vigilância de Doenças Não Transmissíveis. Plano de Ações Estratégicas para o Enfrentamento das Doenças Crônicas e Agravos não Transmissíveis no Brasil 2021-2030. Brasília: Ministério da Saúde; 2021. 118 p.
4.Brasil. Ministério da Saúde. Pesquisa Nacional de Saúde 2019: percepção do estado de saúde, estilos de vida, doenças crônicas e saúde bucal. IBGE; 2020.
5.De Oliveira ML, Santos LMP, Da Silva EN. Direct healthcare cost of obesity in Brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011. PLoS ONE. 2015;10(4):e0121160.
6.Dobbs R, Sawers C, Thompson F, et al. Overcoming obesity: An initial economic analysis. McKinsey Global Institute; 2014.
7.Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284–2291.
8.Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290(2):199–206.
9.Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991–1006.
10.Jeffers M, Rodriguez A, Patel S, Huang L. Integrated management of obesity and hypertension in primary care: challenges and perspectives. J Community Health. 2023;48(2):345–353.
11.Kivits J, Ricci L, Minary L. Interdisciplinary research in public health: the why and the how. J Epidemiol Community Health. 2019;73(12):1061–1062.
12.Machado AP, Lima BM, Laureano MG, et al. Educational strategies for the prevention of diabetes, hypertension, and obesity. Rev Assoc Med Bras. 2016;62(8):800–808.
13.Malachias MVB, et al. 7ª Diretriz Brasileira de Hipertensão Arterial. Arq Bras Cardiol. 2016;107(3 Suppl 3):1–103.
14.Malta DC, Szwarcwald CL, Barros MBA, et al. A epidemiologia das doenças crônicas no Brasil. Rev Bras Epidemiol. 2020;23:e200010.
15.Mendes EV. As redes de atenção à saúde. Brasília: Organização Pan-Americana da Saúde; 2011.
16.1Nilson EAF, Andrade RCS, Brito DA, Oliveira ML. Custos atribuíveis a obesidade, hipertensão e diabetes no Sistema Único de Saúde, Brasil, 2018. Rev Panam Salud Publica. 2020;44:e32.
17.Oshman L, Othman A, Furst W, Heisler M, et al. Primary care providers’ perceived barriers to obesity treatment and opportunities for improvement: a mixed methods study. PLoS ONE. 2023;18(4):e0284474.
18.Silva RM, Andrade SC, Ramos EO. Associação entre obesidade e hipertensão arterial: revisão narrativa. Rev Bras Obes Nut Emagrecimento. 2020;14(85):412–419.
19.Starfield B. Primary Care: balancing health needs, services and technology. Oxford University Press; 2002.
20.Talukdar D, Seenivasan S, Cameron AJ, Sacks G. The association between national income and adult obesity prevalence: empirical insights into temporal patterns and moderators using 40 years of data across 147 countries. PLoS ONE. 2020;15(5):e0232236.
21.Tremmel M, Gerdtham UG, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14(4):435.
22.Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356.
23.Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127–e248.
24.WHO. World Health Organization. Noncommunicable diseases. Geneva: WHO; 2021.
25.World Health Organization. WHO guideline on the prevention and management of hypertension. Geneva: WHO; 2025. 82 p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Filipe Augusto Baier de Andrade, Adalberto Ferreira Junior, Erildo Vicente Muller, Dionizia Xavier Scomparin, Vinícius Custódio

This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
- O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.